نتایج جستجو برای: پروتوآنکوژن ret

تعداد نتایج: 4065  

Journal: :Endocrinology 2014
Esther Diaz-Rodriguez Angela R Garcia-Rendueles Alejandro Ibáñez-Costa Ester Gutierrez-Pascual Montserrat Garcia-Lavandeira Alfonso Leal Miguel A Japon Alfonso Soto Eva Venegas Francisco J Tinahones Juan A Garcia-Arnes Pedro Benito Maria Angeles Galvez Luis Jimenez-Reina Ignacio Bernabeu Carlos Dieguez Raul M Luque Justo P Castaño Clara V Alvarez

Acromegaly is caused by somatotroph cell adenomas (somatotropinomas [ACROs]), which secrete GH. Human and rodent somatotroph cells express the RET receptor. In rodents, when normal somatotrophs are deprived of the RET ligand, GDNF (Glial Cell Derived Neurotrophic Factor), RET is processed intracellularly to induce overexpression of Pit1 [Transcription factor (gene : POUF1) essential for transcr...

Journal: :Journal of medical genetics 2011
Cécile Jeanpierre Guillaume Macé Mélanie Parisot Vincent Morinière Audrey Pawtowsky Marion Benabou Jelena Martinovic Jeanne Amiel Tania Attié-Bitach Anne-Lise Delezoide Philippe Loget Patricia Blanchet Dominique Gaillard Marie Gonzales Wassila Carpentier Patrick Nitschke Frédéric Tores Laurence Heidet Corinne Antignac Rémi Salomon

BACKGROUND The RET/GDNF signalling pathway plays a crucial role during development of the kidneys and the enteric nervous system. In humans, RET activating mutations cause multiple endocrine neoplasia, whereas inactivating mutations are responsible for Hirschsprung disease. RET mutations have also been reported in fetuses with renal agenesis, based on analysis of a small series of samples. OB...

Journal: :The Journal of clinical endocrinology and metabolism 2011
Hans H G Verbeek Maria M Alves Jan-Willem B de Groot Jan Osinga John T M Plukker Thera P Links Robert M W Hofstra

CONTEXT Medullary and papillary thyroid carcinoma (MTC and PTC) are two types of thyroid cancer that can originate from activating mutations or rearrangements in the RET gene. Therapeutic options are limited in recurrent disease, but because RET is a tyrosine kinase (TK) receptor involved in cellular growth and proliferation, treatment with a TK inhibitor might be promising. Several TK inhibito...

2016
Xuan Su Zhaoqu Li Caiyun He Weichao Chen Xiaoyan Fu Ankui Yang

BACKGROUND RET/PTC rearrangements have been identified as a specific genetic event in papillary thyroid cancer (PTC). We conducted this meta-analysis to identify an enriched population who were more likely to occur RET/PTC fusion genes. METHODS All relevant studies in the PubMed, Web of Science, and Embase databases were searched up to June 2015. The studies found were screened according to o...

1998
Richard R. Hardy

Em-ret mice carrying an RFP/RET fusion gene under the transcriptional control of the immunoglobulin heavy chain enhancer develop B lineage leukemias/lymphomas. We have characterized B-cell development in these mice before the onset of clinical disease to determine the steps involved in leukemogenesis. Flow cytometry reveals that the CD45R1CD431CD241BP-11 late pro–B-cell population is markedly e...

2009
Maxim M. Bespalov

1. LITERATURE REVIEW .........................................................................................1 1.1. Growth factors and neurotrophic factors ..............................................................1 1.2. GDNF family ligands ...........................................................................................5 GFLs structure and receptor complexes .......................

2018
Cristina Romei Raffaele Ciampi Francesca Casella Alessia Tacito Liborio Torregrossa Clara Ugolini Fulvio Basolo Gabriele Materazzi Paolo Vitti Rossella Elisei

Purpose Medullary Thyroid Cancer (MTC) whose pathogenesis is strictly related to RET proto-oncogene alterations, has been shown to have a heterogenic RET mutation profile in subpopulations of MTC. The aim of our study was to investigate the RET somatic mutation profile in primary MTC and in the corresponding metastatic tissues in a series of advanced metastatic cases. Results This study demon...

Journal: :Journal of medical genetics 2000
J R Hansford L M Mulligan

Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome characterised by medullary thyroid carcinoma (MTC), with or without phaeochromocytoma and hyperparathyroidism. MEN 2 is unusual among cancer syndromes as it is caused by activation of a cellular oncogene, RET. Germline mutations in the gene encoding the RET receptor tyrosine kinase are found in the vast majority of MEN ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1998
I Bongarzone P Vigneri L Mariani P Collini S Pilotti M A Pierotti

The papillary carcinoma family (PCF) of thyroid tumors includes a wide variety of neoplastic entities regarded as well-differentiated, poorly differentiated, and undifferentiated papillary thyroid carcinomas. Recent studies have established the presence of alternative oncogenic rearrangements of the RET and NTRK1 genes in a consistent fraction (< or = 50%) of papillary thyroid tumors. RET oncog...

Journal: :Journal of the National Cancer Institute 2004
Giuditta Cuccuru Cinzia Lanzi Giuliana Cassinelli Graziella Pratesi Monica Tortoreto Giovanna Petrangolini Ettore Seregni Antonia Martinetti Diletta Laccabue Chiara Zanchi Franco Zunino

BACKGROUND The RET proto-oncogene encodes a receptor tyrosine kinase. RET oncogenes arise through sporadic and inherited gene mutations and are involved in the etiopathogenesis of medullary thyroid carcinoma, a cancer that responds poorly to conventional chemotherapy. Medullary thyroid carcinoma is a component of multiple endocrine neoplasia type 2 or MEN2 syndromes. METHODS We investigated t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید